Trial · NCT02681913
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 6-hour cardiac Troponin T (cTnT) release | 6 hours post-operative | The primary end point is 6-hour cTnT release |
| Secondary | 18-hour cardiac Troponin T (cTnT) area under the curve (AUC) release | cardiac Troponin T (cTnT) AUC will be assessed at different time points, the latest up to 18 hours after ICU arrival | 18-hour postoperative AUC release of cardiac troponin T Routine blood samples pre-operatively from peripheral blood (T0); post-operatively, from peripheral blood, at arrival at ICU (T1) and 6 hours after arrival at ICU (T2), and 18 hours after arrival at ICU (T3). |
| Secondary | Incidence of myocardial injury on 12-lead ECG | participants will be followed for the duration of ICU stay, an expected average of 2 days | Incidence of myocardial injury on 12-lead ECG * New-onset Left bundle branch block (LBBB) * New-onset Q wave |
| Secondary | Vasoactive-inotropic score | participants will be followed for the duration of ICU stay, an expected average of 2 days | The hourly doses of the following inotropic and vasoactive medications are recorded for the first 18 h after post-operative admission to the ICU: dopamine, dobutamine, epinephrine, norepinephrine, milrinone and vasopressin. |
| Secondary | Vasoconstrictor usage | participants will be followed for the duration of ICU stay, an expected average of 2 days | Vasoconstrictor usage yes/no |
| Secondary | Incidence of new onset Atrial fibrillation (AF) | participants will be followed for the duration of ICU stay, an expected average of 2 days | Incidence of new onset AF |
| Secondary | Routine blood samples | Routine blood samples will be assessed at different time points, the latest up to 6 hours after ICU arrival | The amount of creatine kinase MB (CK-MB) and Creatinine at different time intervals. preoperatively from peripheral blood (T0); post-operatively, from peripheral blood, at arrival at ICU (T1) and 6 hours after arrival at ICU (T2) |
| Secondary | Mean arterial pressure (MAP) | participants will be followed for the duration of ICU stay, an expected average of 2 days | Haemodynamic monitoring |
| Secondary | postoperative left ventricular ejection fraction (LVEF) | postoperative after skin closure, an expected average of 3 hours after starting surgery | 3-D transesophageal echocardiography (TEE) postoperative left ventricular ejection fraction (LVEF) after skin closure |
| Secondary | Wall Motion Score Index (WMSI) | postoperative after skin closure, an expected average of 3 hours after starting surgery | 3-D transesophageal echocardiography (TEE) Wall Motion Score Index (WMSI) after skin closure |
| Secondary | Heart rate (HR) | participants will be followed for the duration of ICU stay, an expected average of 2 days | Haemodynamic monitoring. Heart rate will be measured in beats per minute (bpm). |
| Secondary | Cardiac index (CI) | participants will be followed for the duration of ICU stay, an expected average of 2 days | Cardiac index (CI) is a haemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA) |
| Secondary | Systemic vascular resistance index (SVRI) | participants will be followed for the duration of ICU stay, an expected average of 2 days | SVRI = 80 x (MAP - RAP)/CI MAP = Mean Arterial Pressure (mmHg) RAP = Right Arterial Pressure (mmHg) CI = Cardiac Index (L/min/m2) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02681913/registered